Clinical Trials Directory

Trials / Conditions / Epilepsy, Tonic-Clonic

Epilepsy, Tonic-Clonic

13 registered clinical trials studyying Epilepsy, Tonic-Clonic — 2 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationClinical Trial of Vormatrigine in Adult Patients With Epilepsy
NCT07287163
Praxis Precision MedicinesPhase 3
RecruitingA Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
NCT06967012
Affiliated Hospital of Nantong UniversityPhase 4
CompletedPivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
NCT04770337
Neuroelectrics CorporationN/A
CompletedEpiWatch: Evaluation of a Non-EEG Physiological Signal Based Seizure Monitoring System
NCT05059002
EpiWatch, Inc.N/A
WithdrawnXLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)
NCT04282681
LivaNova—
TerminatedEmbrace and Quality of Life
NCT03831802
Centre Hospitalier Universitaire VaudoisN/A
CompletedMicroburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
NCT03446664
LivaNovaN/A
CompletedTopiramate Bioequivalence Study Brazil - Fast
NCT01439438
GlaxoSmithKlinePhase 1
CompletedMonotherapy With Levetiracetam in Patients Suffering From Epilepsy.
NCT00150813
UCB Pharma SAPhase 3
CompletedStudy Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primar
NCT00104416
GlaxoSmithKlinePhase 3
CompletedMonotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.
NCT00150787
UCB PharmaPhase 3
CompletedTreatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
NCT00043901
GlaxoSmithKlinePhase 4
CompletedA Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed o
NCT00231556
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3